Ginette 35: Comprehensive Hormonal Therapy for PCOS and Acne
Ginette-35
| Product dosage: 2.035mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 42 | $1.88 | $79.00 (0%) | 🛒 Add to cart |
| 63 | $1.76 | $118.50 $111.00 (6%) | 🛒 Add to cart |
| 84 | $1.69 | $158.00 $142.00 (10%) | 🛒 Add to cart |
| 126 | $1.64 | $237.00 $207.00 (13%) | 🛒 Add to cart |
| 168 | $1.60
Best per pill | $316.00 $269.00 (15%) | 🛒 Add to cart |
Synonyms | |||
Ginette 35 is a combined oral contraceptive and antiandrogenic medication, widely prescribed for the management of polycystic ovary syndrome (PCOS) and moderate to severe acne in women. It contains a balanced formulation of ethinylestradiol and cyproterone acetate, which work synergistically to regulate hormonal imbalances, suppress ovarian androgen production, and improve dermatological conditions. This product is indicated for women requiring both contraception and hormonal regulation, providing a dual therapeutic approach under medical supervision.
Features
- Contains 2 mg cyproterone acetate and 0.035 mg ethinylestradiol per tablet
- 21-day active tablet regimen followed by a 7-day placebo or break period
- Antiandrogenic and estrogenic activity for hormonal regulation
- Packaged in calendar blister packs for adherence
- Requires prescription and medical oversight
Benefits
- Effectively reduces sebum production and improves treatment-resistant acne
- Regulates menstrual cycles in women with PCOS
- Decreases hirsutism and androgen-related symptoms
- Provides reliable contraception when taken correctly
- Helps prevent ovarian cysts and endometrial hyperplasia
Common use
Ginette 35 is primarily prescribed for women experiencing androgen-dependent conditions such as polycystic ovary syndrome (PCOS) with manifestations including acne, seborrhea, mild hirsutism, and oligomenorrhea. It is also indicated for the treatment of moderate to severe acne that has proven resistant to topical treatments and oral antibiotics. The medication is suitable for women of reproductive age who require both hormonal therapy and contraception.
Dosage and direction
Take one tablet daily at approximately the same time each day for 21 consecutive days, followed by a 7-day tablet-free interval. Menstruation usually occurs during this break. Begin the next pack on the 8th day, regardless of whether bleeding has stopped. For first-time users, start on day 1 of the menstrual cycle. If switching from another hormonal contraceptive, consult specific guidelines for transition. Take with water, with or without food.
Precautions
Medical supervision is required before and during treatment. Regular monitoring of blood pressure, liver function, and metabolic parameters is recommended. Discontinue use 4 weeks before elective surgery or periods of prolonged immobilization due to thrombosis risk. Use with caution in patients with diabetes, hypertension, or hyperlipidemia. Not recommended for smokers over age 35. Report any unusual headaches, visual disturbances, or chest pain immediately.
Contraindications
- History or presence of venous or arterial thrombosis
- Severe hepatic disease or liver tumors
- Known or suspected hormone-dependent malignancies
- Undiagnosed abnormal genital bleeding
- Hypersensitivity to any component
- Pregnancy or breastfeeding
- Pancreatitis with hypertriglyceridemia
Possible side effects
Common: nausea, headache, breast tenderness, mood changes, weight changes. Less common: hypertension, glucose intolerance, chloasma. Rare but serious: thromboembolic events, hepatic adenomas, gallbladder disease. Most side effects diminish after the first few cycles. Persistent or severe symptoms require medical evaluation.
Drug interaction
Interacts with hepatic enzyme inducers (e.g., rifampicin, phenytoin, St. John’s wort) which may reduce efficacy. Antibiotics like ampicillin and tetracyclines might decrease contraceptive effectiveness. May alter the metabolism of cyclosporine, theophylline, and lamotrigine. Concurrent use with other hormonal therapies is not recommended.
Missed dose
If less than 12 hours late: take missed tablet immediately and continue schedule. If more than 12 hours late: take missed tablet as soon as remembered, and use additional contraception for next 7 days. If missed during the first week and unprotected intercourse occurred, consider emergency contraception. Consult package insert for detailed missed dose protocols based on cycle week.
Overdose
Symptoms may include nausea, vomiting, and withdrawal bleeding. No specific antidote exists. Provide symptomatic treatment. Monitor for electrolyte imbalances in cases of significant ingestion. Long-term consequences are unlikely due to the medication’s hormonal nature.
Storage
Store below 25°C in original packaging. Protect from light and moisture. Keep out of reach of children. Do not use after expiration date.
Disclaimer
This information is for educational purposes and does not replace professional medical advice. Ginette 35 is a prescription medication and should only be used under medical supervision. Individual response may vary. Always follow your healthcare provider’s instructions regarding use, monitoring, and discontinuation.
Reviews
Clinical studies demonstrate significant improvement in acne lesions and hormonal parameters in women with PCOS. Users report high satisfaction with dermatological and menstrual cycle regulation effects. Medical professionals emphasize the importance of proper patient selection and monitoring to maximize benefits and minimize risks.